SIMPLAAFY Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1857 participants.

Also called NCT06521463

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 1,857 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06521463
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06521463. Randomized; single masking; primary purpose prevention. Start 2024-10-01 (actual); primary completion 2026-07-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SIMPLAAFY Clinical Trial
Acronym
SIMPLAAFY
Condition
Stroke
Condition
Bleeding
Intervention (Device)
WATCHMAN FLX Pro LAAC Device
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct06521463
Content hash
d2532d46d52255e89120b6b3d78613b03408c0f9b63005d53b6643cc1da4fb11